Genmab — September 2020

[Stockwatch1]

We anticipate that it will take months before this is resolved, putting lots of
uncertainty on the stock in the meantime. We are downgrading our rating to SELL and
putting our TP under review.

[SwingSun]

i simpel fodfejl ligner det...aftalen har jo været kendt længe.

[SwingSun]

yes stock this will happen all over now.

[BioShare]

Der var noget mere kærlighed i luften da JNJ valgte at udbetale milestone til GEN for "næsten" at have nået salgstallene Mit gæt er at det helt sikkert er aftalen med Abbvie, som har kølet tingene ned.

[E_L]

in hindsight, let's be glad they diversified a bit
with big partners with Abbvie

[nohope]

De udbetalte den fordi der var fastlagte valutakurser som løftede salget over grænsen.

[Sukkeralf]

Could it be that Janssen just want Genmab to pay their Halozymes bit and throw in the big thing about patent expire just to frigthen Genmab

[Bulder]

My thought

[Sukkeralf]

I actualy think its fair that Genmab takes part in the Halozyme thing but the patent expire thing seems ridicously unfair

[SwingSun]

naa sukker its the deal with abbvie i think. someone got a bit disappointed,,,,but ofc it could be some kind of leverage also.

[SwingSun]

what puzzles me is how can a bunch of lawq people miss this fact,,,,,

[SwingSun]

the patent dates

[SwingSun]

its a disaster

[Sukkeralf]

Genmab said quite early that they were in deep talks with only one partner so that mean Janssen must have been out for some time

[SwingSun]

those are tough business people.

[SwingSun]

they dont care about whats formerly agreed

[StockBull]

It is and thats the reason Genmab looking for new attorney

[SwingSun]

they only care about whats in writing

[SwingSun]

he should be crucified and pay the fault expences lol

[SwingSun]

they used one person inhouse only??